Teclistamab by Johnson & Johnson is a new hope for refractory or relapsing multiple myeloma.
Combination drug invented by RedHill Biopharma will get rid of Helicobacter pylori infection in 90% of patients.
Oral opaganib will reduce the likelihood of death and accelerate recovery in hospitalized patients with COVID-19.
Tisotumab vedotin for therapy of previously treated recurrent or metastatic cervical cancer.
Atezolizumab with bevacizumab: a powerful immunotherapy approach for first-line therapy of liver cancer.